Binding Method for Detection of Muscarinic Acetylcholine Receptors in Receptor’s Natural Environment

[1]  M. Kainoh,et al.  Pharmacologically distinct phenotypes of α1B‐adrenoceptors: variation in binding and functional affinities for antagonists , 2014, British journal of pharmacology.

[2]  T. Masuoka,et al.  Intracellular localization of the M1 muscarinic acetylcholine receptor through clathrin-dependent constitutive internalization is mediated by a C-terminal tryptophan-based motif , 2014, Journal of Cell Science.

[3]  N. Matsuki,et al.  Novel contribution of cell surface and intracellular M1‐muscarinic acetylcholine receptors to synaptic plasticity in hippocampus , 2013, Journal of neurochemistry.

[4]  Arthur Christopoulos,et al.  Bridging the gap: bitopic ligands of G-protein-coupled receptors. , 2013, Trends in pharmacological sciences.

[5]  H. Ikeuchi,et al.  M1 is a major subtype of muscarinic acetylcholine receptors on mouse colonic epithelial cells , 2013, Journal of Gastroenterology.

[6]  A. Nishimune,et al.  Regional quantification of muscarinic acetylcholine receptors and β‐adrenoceptors in human airways , 2012, British journal of pharmacology.

[7]  A. Nishimune,et al.  Phenotype pharmacology of lower urinary tract α1‐adrenoceptors , 2012, British journal of pharmacology.

[8]  A. Nishimune,et al.  Re-Evaluation of Nicotinic Acetylcholine Receptors in Rat Brain by a Tissue-Segment Binding Assay , 2011, Front. Pharmacol..

[9]  A. Nishimune,et al.  Influence of Tissue Integrity on Pharmacological Phenotypes of Muscarinic Acetylcholine Receptors in the Rat Cerebral Cortex , 2011, Journal of Pharmacology and Experimental Therapeutics.

[10]  A. Nishimune,et al.  Intracellular distribution of functional M1‐muscarinic acetylcholine receptors in N1E‐115 neuroblastoma cells , 2011, Journal of neurochemistry.

[11]  D. Bylund,et al.  Radioligand binding methods for membrane preparations and intact cells. , 2011, Methods in molecular biology.

[12]  Laurence J. Miller,et al.  Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery , 2010, Pharmacological Reviews.

[13]  A. Anisuzzaman,et al.  Identification of M(1) muscarinic receptor subtype in rat stomach using a tissue segment binding method, and the effects of immobilization stress on the muscarinic receptors. , 2008, European journal of pharmacology.

[14]  A. Anisuzzaman,et al.  Different affinities of native alpha1B-adrenoceptors for ketanserin between intact tissue segments and membrane preparations. , 2008, European journal of pharmacology.

[15]  J A Peters,et al.  Guide to Receptors and Channels (GRAC), 3rd edition , 2008, British journal of pharmacology.

[16]  H. Akino,et al.  Assessment of muscarinic receptor subtypes in human and rat lower urinary tract by tissue segment binding assay. , 2008, Journal of Pharmacological Sciences.

[17]  S. Hill,et al.  Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates , 2007, Trends in pharmacological sciences.

[18]  R A John Challiss,et al.  "Phenotypic" pharmacology: the influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology. , 2007, Biochemical pharmacology.

[19]  S. Morishima,et al.  Pharmacological evaluation of plasma membrane beta-adrenoceptors in rat hearts using the tissue segment binding method. , 2006, Life sciences.

[20]  A. Anisuzzaman,et al.  Quantifying receptor properties: the tissue segment binding method - a powerful tool for the pharmacome analysis of native receptors. , 2005, Journal of pharmacological sciences.

[21]  Takashi Tanaka,et al.  Identification of α-1L Adrenoceptor in Rabbit Ear Artery , 2004, Journal of Pharmacology and Experimental Therapeutics.

[22]  Li Zhang,et al.  Alpha‐1 adrenoceptors: evaluation of receptor subtype‐binding kinetics in intact arterial tissues and comparison with membrane binding , 2004, British journal of pharmacology.

[23]  C. V. van Koppen,et al.  Regulation of muscarinic acetylcholine receptor signaling. , 2003, Pharmacology & therapeutics.

[24]  J. Faber,et al.  Expression of α-Adrenoceptor Subtypes by Smooth Muscle Cells and Adventitial Fibroblasts in Rat Aorta and in Cell Culture , 2001 .

[25]  J. Balligand,et al.  Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling , 2000, The EMBO journal.

[26]  A. Ford,et al.  Characterization of an atypical muscarinic cholinoceptor mediating contraction of the guinea‐pig isolated uterus , 1998, British journal of pharmacology.

[27]  J. Pennefather,et al.  Pharmacological characterization of muscarinic receptors in the uterus of oestrogen‐primed and pregnant rats , 1998, British journal of pharmacology.

[28]  J. Edwardson,et al.  Intracellular trafficking of the muscarinic acetylcholine receptor: importance of subtype and cell type. , 1996, Molecular pharmacology.

[29]  T. Kenakin,et al.  On the importance of the "antagonist assumption" to how receptors express themselves. , 1995, Biochemical pharmacology.

[30]  F. Ehlert,et al.  Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain. , 1990, The Journal of pharmacology and experimental therapeutics.

[31]  A. Michel,et al.  Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites , 1989, British journal of pharmacology.

[32]  R. Sherman-Gold.  Neurotransmitter receptor binding, 2nd edn: edited by Henry I. Yamamura, S. J. Enna and Michael J. Kuhar, Raven Press, 1985. US$58.00 (xiv + 242 pages), ISBN 0 88167 027 8 , 1985 .

[33]  J. Galper,et al.  The biphasic response of muscarinic cholinergic receptors in cultured heart cells to agonists. Effects on receptor number and affinity in intact cells and homogenates. , 1982, The Journal of biological chemistry.

[34]  R. Alexander,et al.  Regulation of the Postsynaptic α‐Adrenergic Receptor in Rat Mesenteric Artery: Effects of Chemical Sympathectomy and Epinephrine Treatment 1981 , 1981, Circulation research.

[35]  J. Schwartz,et al.  Pharmacological specificity of brain histamine H2-receptors differs in intact cells and cell-free preparations , 1980, Nature.

[36]  H. Rang,et al.  The uptake of atropine and related drugs by intestinal smooth muscle of the guinea-pig in relation to acetylcholine receptors , 1965, Proceedings of the Royal Society of London. Series B. Biological Sciences.